Patent assignee · US · COMPANY

Afferent Pharmaceuticals, Inc.

12Patents
12Active
12Granted
47Portfolio score

Filing activity: Aug 22, 2014 → Apr 30, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US9284279B2 Substituted pyrimidines for treatment of acute cough, chronic cough and urge to cough Human Necessities 12 Active
US10195198B2 Methods and compositions for treating diseases and conditions Human Necessities 2 Active
US10822311B2 Pyrimidines and variants thereof, and uses therefor Chemistry; Metallurgy 2 Active
US9724346B2 Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough Human Necessities 2 Active
US10206922B2 Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough Human Necessities 2 Active
US10662162B2 Pyrimidines and variants thereof, and uses therefor Chemistry; Metallurgy 2 Active
US10676444B2 Crystalline salts and polymorphs of a P2X3 antagonist Chemistry; Metallurgy 1 Active
US11260056B2 Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of cough Human Necessities 0 Active
US11230532B2 Pyrimidines and variants thereof, and uses therefor Chemistry; Metallurgy 0 Active
US10988460B2 Substituted pyrazole-pyrimidines, variants thereof, and uses therefore Chemistry; Metallurgy 0 Active
US11230533B2 Crystalline salts and polymorphs of a P2X3 antagonist Chemistry; Metallurgy 0 Active
US10543211B2 Methods and compositions for treating diseases and conditions Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.